Microfluidic Platform Integrated with Carbon Nanofibers-Decorated Gold Nanoporous Sensing Device for Serum PSA Quantification
Biosensors · 2023
DOI: 10.3390/bios13030390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Emiliano Felici und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Química, Bioquímica y Farmacia, Instituto de Química de San Luis, INQUISAL (UNSL-CONICET), Universidad Nacional de San Luis, Chacabuco 91…. Hauptthemen laut MEDLINE: Nanofibers, Nanopores, Metal Nanoparticles, Prostatic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of San Luis, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, University of Granada.
Abstract (Originalsprache)
Prostate cancer is a disease with a high incidence and mortality rate in men worldwide. Serum prostate-specific antigens (PSA) are the main circulating biomarker for this disease in clinical practices. In this work, we present a portable and reusable microfluidic device for PSA quantification. This device comprises a polymethyl methacrylate microfluidic platform coupled with electrochemical detection. The platinum working microelectrode was positioned in the outflow region of the microchannel and was modified with carbon nanofibers (CNF)-decorated gold nanoporous (GNP) structures by the dynamic hydrogen bubble template method, through the simultaneous electrodeposition of metal precursors in the presence of CNF. CNF/GNP structures exhibit attractive properties, such as a large surface to volume ratio, which increases the antibody’s immobilization capacity and the electroactive area. CNFs/GNP structures were characterized by scanning electron microscopy, energy dispersive spectrometry, and cyclic voltammetry. Anti-PSA antibodies and HRP were employed for the immune-electrochemical reaction. The detection limit for the device was 5 pg mL−1, with a linear range from 0.01 to 50 ng mL−1. The coefficients of variation within and between assays were lower than 4.40%, and 6.15%, respectively. Additionally, its clinical performance was tested in serum from 30 prostate cancer patients. This novel device was a sensitive, selective, portable, and reusable tool for the serological diagnosis and monitoring of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Química, Bioquímica y Farmacia, Instituto de Química de San Luis, INQUISAL (UNSL-CONICET), Universidad Nacional de San Luis, Chacabuco 917, San Luis D5700BWS, Argentina.
- GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government PTS, Granada, Avenida de la Ilustración, 114, 18016 Granada, Spain.
- IBS Granada, Institute of Biomedical Research, Avenida de Madrid 15, 18012 Granada, Spain.
- UGC Cartuja, Distrito Sanitario Granada Metropolitano. Calle Joaquina Eguaras, 2, 18013 Granada, Spain.
- Laboratório de Automação e Instrumentação Analítica, Department of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, Av. Professor Lineu Prestes 748, São Paulo 05508-000, Brazil.
ORCID-Profile: Martín A Fernández-Baldo
Förderung
- National University of San Luis
- Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research
- University of Granada
- Agencia Nacional de Promoción Científica y Tecnológica
- National Scientific and Technical Research Council
- Universidad Nacional de San Luis
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) (Argentina)
- GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada, Andalusian Regional Government
Zitieren
APA
Felici, E., Regiart, M. D., Pereira, S. V., Ortega, F. G., Angnes, L., Messina, G. A., & Fernández-Baldo, M. A. (2023). Microfluidic Platform Integrated with Carbon Nanofibers-Decorated Gold Nanoporous Sensing Device for Serum PSA Quantification. Biosensors. https://doi.org/10.3390/bios13030390
Vancouver
Felici E, Regiart MD, Pereira SV, Ortega FG, Angnes L, Messina GA, et al. Microfluidic Platform Integrated with Carbon Nanofibers-Decorated Gold Nanoporous Sensing Device for Serum PSA Quantification. Biosensors. 2023. doi:10.3390/bios13030390
BibTeX
@article{Felici2023,
author = {Felici, Emiliano and Regiart, Matías D and Pereira, Sirley V and Ortega, Francisco G and Angnes, Lúcio and Messina, Germán A and Fernández-Baldo, Martín A},
title = {Microfluidic Platform Integrated with Carbon Nanofibers-Decorated Gold Nanoporous Sensing Device for Serum PSA Quantification},
journal = {Biosensors},
year = {2023},
doi = {10.3390/bios13030390}
}
EUVIMED